首页> 中文期刊> 《中国临床保健杂志》 >逆行性胰胆管造影在早期急性胆源性胰腺炎中的应用

逆行性胰胆管造影在早期急性胆源性胰腺炎中的应用

         

摘要

Objective To investigate value of clinical applications of ERCP in patients with acute biliary pancreatitis.Meth-ods A retrospective study was conducted on 120 patients with acute biliary pancreatitis in the Chaohu Hospital of Anhui Medical U-niversity between January 2014 and December 2015.The subjects were divided into two groups:observation group (n =60)and con-trol group (n =60)groups,were respectively treated with ERCP and internal medical therapy.The validity rate,mortality rate and the incidence of complications were recorded.Results The validity rate of the observation group(95.0%)was better than that of the control group (76.7%),the differences were statistically significant (P <0.05 ).The mortality rate of the observation group (1.7%)was lower than the control group(13.3%),the statistically significant differences(P <0.05);The incidence of complica-tions of the observation group(1 1.7%)was lower than the control group(30.0%),the statistically significant differences(P <0.05).Conclusion ERCP is an effective and safe method for the treatment of acute biliary pancreatitis and can be recommended as the first choice of treatment.%目的:探讨逆行性胰胆管造影(ERCP)在早期急性胆源性胰腺炎(ABP)患者中的临床应用价值。方法分析120例早期 ABP 患者的临床资料,采用 ERCP 治疗的患者为60例作为观察组,采用保守治疗的60例患者作为对照组。对两组患者的治疗有效率、病死率以及并发症发生率进行分析。结果观察组患者的治疗有效率(95.0%)与对照组(76.7%)比较,差异有统计学意义(P <0.05);观察组患者的病死率(1.7%)与对照组(13.3%)比较,差异有统计学意义(P <0.05);观察组患者的并发症发生率(11.7%)与对照组(30.0%)比较,差异有统计学意义(P <0.05)。结论采用ERCP 治疗早期 ABP 的有效性和安全性高,可考虑作为 ABP 患者的首选治疗方法。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号